Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
Privia Health Group Inc (NASDAQ: PRVA) closed the day trading at $24.90 up 2.47% from the previous closing price of $24.30. In other words, the price has increased by $2.47 from its previous closing price. On the day, 0.7 million shares were traded. PRVA stock price reached its highest trading level at $24.92 during the session, while it also had its lowest trading level at $23.925.
Ratios:
For a better understanding of PRVA, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.47 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 25.65. For the most recent quarter (mrq), Quick Ratio is recorded 1.88 and its Current Ratio is at 1.88. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on January 10, 2025, initiated with a Buy rating and assigned the stock a target price of $25.
On October 11, 2024, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $23.KeyBanc Capital Markets initiated its Overweight rating on October 11, 2024, with a $23 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 13 ’25 when Mehrotra Parth sold 15,909 shares for $24.52 per share. The transaction valued at 390,089 led to the insider holds 407,234 shares of the business.
Mehrotra Parth sold 13,773 shares of PRVA for $344,187 on May 12 ’25. The Chief Executive Officer now owns 423,143 shares after completing the transaction at $24.99 per share. On May 12 ’25, another insider, Mountcastle David, who serves as the EVP & Chief Financial Officer of the company, sold 3,322 shares for $24.99 each. As a result, the insider received 83,017 and left with 172,909 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRVA now has a Market Capitalization of 3035808000 and an Enterprise Value of 2621989888. As of this moment, Privia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 201.46, and their Forward P/E ratio for the next fiscal year is 74.10. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.25. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.69 while its Price-to-Book (P/B) ratio in mrq is 4.58. Its current Enterprise Value per Revenue stands at 1.456 whereas that against EBITDA is 91.279.
Stock Price History:
The Beta on a monthly basis for PRVA is 0.87, which has changed by 0.47337282 over the last 52 weeks, in comparison to a change of 0.11571348 over the same period for the S&P500. Over the past 52 weeks, PRVA has reached a high of $26.09, while it has fallen to a 52-week low of $15.92. The 50-Day Moving Average of the stock is 6.11%, while the 200-Day Moving Average is calculated to be 16.85%.
Shares Statistics:
Over the past 3-months, PRVA traded about 867.46K shares per day on average, while over the past 10 days, PRVA traded about 837110 shares per day. A total of 121.39M shares are outstanding, with a floating share count of 106.80M. Insiders hold about 12.40% of the company’s shares, while institutions hold 92.88% stake in the company. Shares short for PRVA as of 1745971200 were 3353425 with a Short Ratio of 3.87, compared to 1743379200 on 4168291. Therefore, it implies a Short% of Shares Outstanding of 3353425 and a Short% of Float of 5.0300002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
